Last updated 2026-07-26
- Raised $385k grant, Aug 2024
- Raised Seed round led by AGP Ventures, May 2021
- Raised Pre-Seed round led by ExitValley, Jul 2020
Total raised
$385K
Last: Grant 2024-09
Stage
Seed
Founded
2016
Headcount
28
HQ
Misgav, Israel
Sector
Health Tech & Life Sciences
About
ADVA Biotechnology is an Israel-based private company focused on developing enabling technologies for cell therapy manufacturing. The company was established in 2016 by a group of cell therapy and engineering experts with vast experience in cell therapy cGMP manufacturing and development. Their flagship product, the ADVA X3 platform, is a fully controlled, flexible, and automated cell processing system that leverages unique CAMP (Continuous Adaptive Multi-Parameter) technology. It is designed to streamline autologous cell therapy manufacturing processes, supporting applications like CAR-T, TCR, TIL, NK, Exosomes, and Viruses. The platform aims to provide decentralized, automated, and efficient manufacturing for advanced cell therapies, reducing costs and accelerating the transition from R&D to GMP production.
Funding history · 3 rounds · $385K total
2024-08
Grant
$385K
2021-05
Seed
Undisclosed
★ AGP Ventures
2020-07
Pre-Seed
Undisclosed
★ ExitValley
Headcount over time
From 8 (2020-02) to 24 (2026-03) · +16 (+200%) · 32 points · source: Finder history + radar grounding
Q&A
- What is ADVA Biotechnology's primary focus?
- ADVA Biotechnology is focused on developing enabling technologies for cell therapy manufacturing, specifically an automated autologous cell manufacturing platform called ADVA X3.
- When was ADVA Biotechnology founded?
- ADVA Biotechnology was established in 2016.
- How many employees does ADVA Biotechnology currently have?
- ADVA Biotechnology has 11-50 employees.
- What is the total amount of funding ADVA Biotechnology has raised to date?
- ADVA Biotechnology has raised a total of $25,800,000 USD.
- When was ADVA Biotechnology's most recent funding round and what type was it?
- ADVA Biotechnology's most recent funding was a Grant round in September 2024, raising $385,000.
- Which investor participated in ADVA Biotechnology's Seed round in June 2022?
- Sawari Ventures participated in ADVA Biotechnology's Seed round in June 2022.
- What is the core technology behind ADVA Biotechnology's ADVA X3 platform?
- The ADVA X3 platform leverages unique CAMP (Continuous Adaptive Multi-Parameter) technology for fully controlled, flexible, and automated cell processing.
- What was the nature of the agreement between Lonza and ADVA Biotechnology in August 2022?
- In August 2022, Lonza and ADVA Biotechnology Ltd. agreed to expand the availability and use of automated bioreactors with a license to Lonza's patents.
Team · 3
Ohad Karnieli
Founder · Founder & CEO
R. Ron Elazary-Vulcani
Founder · Founder & Board Member
Barbara Paldus
Founder · Founder & Board Member
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2B
Tags
medical-technologiespatientsbiotechnologymedical-deviceshospitalscancercell-therapyimmunologymanufacturinggenetic-engineeringautomationmonitoring
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | advabio.com/ |
|---|---|
| linkedin.com/company/30096447 | |
| YouTube | youtube.com/channel/UC-MHD-u3j_vRlBMmK-W8Ndg |
Identifiers & details
| Legal name | ADVA Biotechnology Ltd. |
|---|---|
| Founded | 2016 |
| Employees (exact) | 28 |
Radar intelligence
Patents
| EPO | 6 |
|---|
Web history (Wayback)
| Domain | advabio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 5 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515528065 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2016-09-25 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — annual_report (2), shares_capital (1), people (1) |
| Registered address | הדולב 3 תעשיון בר לב |
Recent registry events
| Date | Event |
|---|---|
| 2025-10-29 | דו~ח שנתי |
| 2026-03-22 | הקצאת מניות |
| 2025-08-18 | עדכון בעלי תפקידים |
| 2025-08-18 | דו~ח שנתי-עדכון בעל תפקיד |